穿透性角膜移植术后Ahmed型引流阀植入治疗青光眼
[Implantation of Ahmed-type valve in the treatment of glaucoma, following penetrating keratoplasty].
作者信息
Romaniuk Wanda, Fronczek Mariusz, Szkaradek Paweł, Dorecka Mariola
机构信息
Oddziału Klinicznego Chorób Oczu Slaskiej Akademii Medycznej, Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary w Sosnowcu.
出版信息
Klin Oczna. 2004;106(1-2 Suppl):170-2.
PURPOSE
To evaluate the outcomes of Ahmed glaucoma valve implantation for therapy of glaucoma after penetrating keratoplasty.
MATERIAL AND METHODS
17 Ahmed glaucoma valve implants were placed in 17 eyes with glaucoma after penetrating keratoplasty. The follow up was 1 year. V.A., IOP and index medication were observed before and 1 year after surgery.
RESULTS
The mean preoperative IOP was 29.1 mmHg (+/-6.5) with average medication 2.65 +/- 0.5, 1 year after surgery the mean IOP decreased to 18.4 mmHg +/- 4.7 with 0.7 +/- 0.8 medication. The tube implant successfully controlled glaucoma in 13 eyes (73.5%) at 1 year. The corneal grafts remain clear in 11 eyes (64.7%).
CONCLUSIONS
Implantation of Ahmed glaucoma valve successfully controlled IOP in difficult cases of glaucoma after penetrating keratoplasty.
目的
评估Ahmed青光眼阀植入术治疗穿透性角膜移植术后青光眼的效果。
材料与方法
对17例穿透性角膜移植术后青光眼患者的17只眼植入Ahmed青光眼阀。随访1年。观察手术前后的视力、眼压及降眼压药物使用情况。
结果
术前平均眼压为29.1 mmHg（±6.5），平均使用降眼压药物2.65±0.5种；术后1年，平均眼压降至18.4 mmHg±4.7，使用降眼压药物0.7±0.8种。1年后，13只眼（73.5%）的眼压通过植入物成功得到控制。11只眼（64.7%）的角膜移植片保持透明。
结论
Ahmed青光眼阀植入术能成功控制穿透性角膜移植术后难治性青光眼的眼压。
Zotero 插件